|Articles|January 24, 2008
Antihistamine's new label covers both indoor and outdoor allergies
In a new labeling change, Schering-Plough's Claritin can now treat both indoor and outdoor allergies
Advertisement
Schering-Plough reported that FDA has approved a labeling change for its over-the-counter Claritin (loratadine). The new label now states that the non-drowsy OTC drug relieves allergy symptoms caused by both indoor (or perennial) and outdoor (or seasonal) allergies. Indoor allergens include mold, dust mites, and pet dander, while outdoor allergens cover grass and pollen.
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
GoodRx Offers Wegovy Weight-Loss Pill at Under $150 a Month
2
FDA Approves Denosumab-Mobz as Biosimilar for Prolia, Xgeva
3
HHS Limits Vaccine Recommendations for Childhood Schedules
4
Orforglipron Maintains Weight Loss After Discontinuation of Injectable GLP-1
5